The stock of Motif Bio PLC (LON:MTFB) gapped down by GBX 0.088 today and has GBX 22.32 target or 7.00% below today’s GBX 24.00 share price. The 9 months technical chart setup indicates high risk for the GBX 25.85M company. The gap down was reported on Nov, 22 by Barchart.com. If the GBX 22.32 price target is reached, the company will be worth GBX 1.81 million less.
Gaps down are helpful for identifying a resistance level and to could also be used as a tradeable event. If traders are short the stock and it experiece gap down, then its usually advisable to hold the short for a bigger down move. Back-tests of such patterns show that two-thirds of the these patterns the stock performance worsens after the gap. The area gaps close 91% of the time, the breakaway gaps 1%, the continuation gaps 9% and the exhaustion gaps 64%. The stock decreased 1.03% or GBX 0.25 on November 22, hitting GBX 24. About 3.03M shares traded hands or 354.83% up from the average. Motif Bio PLC (LON:MTFB) has declined 42.42% since April 22, 2016 and is downtrending. It has underperformed by 46.98% the S&P500.
Motif Bio PLC (LON:MTFB) Ratings Coverage
Out of 2 analysts covering Motif Bio Plc (LON:MTFB), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Motif Bio Plc has been the topic of 42 analyst reports since July 23, 2015 according to StockzIntelligence Inc. The rating was maintained by Beaufort Securities on Tuesday, August 25 with “Speculative Buy”. The rating was maintained by Northland Capital on Wednesday, April 20 with “Buy”. The stock of Motif Bio PLC (LON:MTFB) has “Speculative Buy” rating given on Thursday, November 12 by Beaufort Securities. The rating was maintained by Northland Capital on Monday, November 21 with “Buy”. Northland Capital maintained Motif Bio PLC (LON:MTFB) rating on Monday, March 14. Northland Capital has “Buy” rating and GBX 114 price target. The stock of Motif Bio PLC (LON:MTFB) earned “Hold” rating by Beaufort Securities on Wednesday, August 17. On Wednesday, November 25 the stock rating was maintained by Beaufort Securities with “Speculative Buy”. The rating was maintained by Beaufort Securities with “Speculative Buy” on Tuesday, January 26. On Wednesday, October 14 the stock rating was maintained by Beaufort Securities with “Speculative Buy”. The company was maintained on Monday, August 24 by Northland Capital.
More recent Motif Bio PLC (LON:MTFB) news were published by: Reuters.com which released: “BRIEF-Motif Bio Plc’s ADS opens at $5.52 in US market debut” on November 18, 2016. Also Globenewswire.com published the news titled: “Motif Bio plc Announces Pricing Of $25 Million U.S. Initial Public Offering …” on November 18, 2016. Uk.Finance.Yahoo.com‘s news article titled: “Motif Bio Plc (MTFB.L)” with publication date: April 02, 2015 was also an interesting one.
Motif Bio plc is a clinical-stage biopharmaceutical company. The company has a market cap of 25.85 million GBP. The Firm is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It currently has negative earnings. It operates in the development and commercialization of pharmaceutical formulations segment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.